Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
PubMed, Chappell, Kenneth, et al
GIP activation works directly on fat tissue to influence how the body stores and mobilizes fat, improves insulin sensitivity at the cellular level, amplifies GLP-1 appetite suppression, and may improve tolerability by moderating some GI effects
Human evidence - Phase 3 TRANSCEND-T2D-1 (Eli Lilly, March 19, 2026) 537 adults with type 2 diabetes, randomized 1:1:1:1 to retatrutide 4, 9, or 12 mg or placebo
This decision is based on the improved availability of the brand-name medication, ensuring that patients receive FDA-approved drugs that have undergone rigorous safety and efficacy reviews4
Well work with you to determine the appropriate treatment plan and discuss long-term strategies for maintaining a healthy weight
/product/60/070776/1.jpg?3055)
US$ 21.79
US$ 23.27
US$ 25.72
US$ 21.70
US$ 26.36
US$ 27.17
